file1
,
file2
, etc. all in the same folder or directory;
first, locate one of the files with the [Browse...] button. Then alter the
file path in the box above to include '*' character (eg. file*
).
Wildcard '?' to blanket only one character works too.Historiographs |
Grand Totals: LCS 52148, GCS 386809, CR 295585 Collection span: 1945 - 2011 | |
Word(i) List (10782) Word count: 98586, All words count: 135005 |
# | Word | Recs | TLCS | TGCS |
---|---|---|---|---|
201 | COMPARISON | 73 | 232 | 923 |
202 | MISMATCHED | 73 | 516 | 2913 |
203 | ANTIGENS | 72 | 241 | 1188 |
204 | EXPERIENCE | 72 | 315 | 1358 |
205 | MHC | 72 | 367 | 879 |
206 | MYELOGENOUS | 72 | 691 | 4260 |
207 | NATURAL | 72 | 437 | 2432 |
208 | TREATED | 72 | 433 | 2103 |
209 | MECHANISMS | 71 | 517 | 1628 |
210 | TANDEM | 71 | 521 | 868 |
211 | DIFFERENT | 70 | 381 | 1096 |
212 | FUNCTIONAL | 70 | 316 | 2805 |
213 | BASED | 68 | 235 | 743 |
214 | METHOD | 68 | 339 | 59638 |
215 | ACCEPTANCE | 67 | 1700 | 3895 |
216 | ADOPTIVE | 67 | 383 | 1696 |
217 | RISK | 67 | 487 | 2085 |
218 | THYMIC | 67 | 524 | 1908 |
219 | DEPLETED | 66 | 195 | 485 |
220 | GENETIC | 66 | 388 | 1603 |
221 | IMPACT | 66 | 327 | 1049 |
222 | KINETICS | 66 | 454 | 975 |
223 | STATUS | 66 | 189 | 605 |
224 | MYELOABLATIVE | 65 | 373 | 1228 |
225 | REPORT | 65 | 383 | 1612 |
226 | SHORT | 65 | 385 | 723 |
227 | T-CELLS | 65 | 460 | 2125 |
228 | ACTIVATION | 64 | 181 | 2130 |
229 | MESENCHYMAL | 64 | 212 | 11211 |
230 | VITRO | 64 | 216 | 1697 |
# | Word | Recs | TLCS | TGCS |
231 | CYCLOPHOSPHAMIDE | 63 | 325 | 1148 |
232 | DOSE | 63 | 255 | 1221 |
233 | MATERNAL | 63 | 359 | 1646 |
234 | AVIAN | 62 | 215 | 2585 |
235 | EMBRYOS | 62 | 194 | 1989 |
236 | IMPLICATIONS | 62 | 326 | 1098 |
237 | NEURAL | 62 | 107 | 3234 |
238 | PREVENTS | 62 | 637 | 2707 |
239 | REFRACTORY | 62 | 400 | 1602 |
240 | ADVANCED | 61 | 204 | 950 |
241 | CHAIN | 61 | 357 | 1330 |
242 | DONOR-DERIVED | 61 | 240 | 1220 |
243 | HUMANIZED | 61 | 282 | 2226 |
244 | PRIMARY | 61 | 229 | 1575 |
245 | RITUXIMAB | 61 | 91 | 2579 |
246 | BETA | 60 | 205 | 1999 |
247 | CLASS | 60 | 214 | 820 |
248 | FOLLOWED | 60 | 450 | 1300 |
249 | INJURY | 60 | 98 | 1656 |
250 | TRANSFUSION | 60 | 440 | 1172 |
251 | VASCULARIZED | 60 | 400 | 721 |
252 | CASE | 59 | 158 | 896 |
253 | DIFFERENTIATION | 59 | 245 | 3734 |
254 | PORCINE | 59 | 361 | 2146 |
255 | TWO | 59 | 144 | 987 |
256 | IMMUNOLOGICAL | 58 | 225 | 1358 |
257 | INFLUENCE | 58 | 411 | 1876 |
258 | LOW-DOSE | 58 | 362 | 1053 |
259 | NORMAL | 58 | 450 | 11379 |
260 | REAL-TIME | 58 | 239 | 759 |
# | Word | Recs | TLCS | TGCS |
261 | SICKLE | 58 | 372 | 1274 |
262 | BODY | 57 | 771 | 1530 |
263 | INFECTION | 57 | 98 | 1257 |
264 | REGIMENS | 57 | 485 | 1545 |
265 | THERAPEUTIC | 57 | 73 | 986 |
266 | DELETION | 56 | 912 | 1887 |
267 | FUSION | 56 | 128 | 2245 |
268 | SOLID | 56 | 266 | 787 |
269 | AMPLIFICATION | 55 | 893 | 2705 |
270 | ASSESSMENT | 55 | 343 | 882 |
271 | PHASE | 55 | 253 | 3181 |
272 | TRANSGENIC | 55 | 74 | 1788 |
273 | XENOTRANSPLANTATION | 55 | 168 | 892 |
274 | RECOMBINANT | 54 | 259 | 1796 |
275 | SYSTEMIC | 54 | 510 | 1666 |
276 | CYTOTOXIC | 53 | 544 | 2345 |
277 | FULLY | 53 | 551 | 1624 |
278 | IMMUNODEFICIENT | 53 | 142 | 1105 |
279 | LYMPHOBLASTIC | 53 | 261 | 1136 |
280 | THYMUS | 53 | 237 | 3293 |
281 | APLASTIC | 52 | 171 | 515 |
282 | BUSULFAN | 52 | 218 | 848 |
283 | FACTORS | 52 | 153 | 700 |
284 | KILLER | 52 | 252 | 1937 |
285 | RECOVERY | 52 | 118 | 758 |
286 | APPLICATION | 51 | 151 | 638 |
287 | HLA-IDENTICAL | 51 | 391 | 2118 |
288 | MUSCLE | 51 | 190 | 3748 |
289 | PHENOTYPE | 51 | 234 | 1563 |
290 | PRIMATES | 51 | 449 | 1816 |
# | Word | Recs | TLCS | TGCS |
291 | SPLEEN | 51 | 115 | 431 |
292 | APPROACH | 50 | 527 | 878 |
293 | B-CELL | 50 | 118 | 2145 |
294 | DEFICIENCY | 50 | 76 | 648 |
295 | GENERATION | 50 | 107 | 1326 |
296 | HYBRIDIZATION | 50 | 338 | 1129 |
297 | RELAPSED | 50 | 492 | 3395 |
298 | BASILIXIMAB | 49 | 227 | 1735 |
299 | ESTABLISHMENT | 49 | 316 | 860 |
300 | LEVELS | 49 | 257 | 854 |
301 | PROLONGED | 49 | 224 | 1206 |
302 | RECEPTORS | 49 | 164 | 1658 |
303 | REMISSION | 49 | 146 | 1059 |
304 | FORMATION | 48 | 62 | 1612 |
305 | IMMUNOSUPPRESSIVE | 48 | 446 | 1253 |
306 | INHIBITION | 48 | 67 | 975 |
307 | MODELS | 48 | 67 | 667 |
308 | MYELODYSPLASTIC | 48 | 154 | 687 |
309 | QUANTIFICATION | 48 | 202 | 603 |
310 | REQUIRED | 48 | 361 | 1461 |
311 | DERIVED | 47 | 270 | 5645 |
312 | IDENTIFICATION | 47 | 168 | 1474 |
313 | INTESTINAL | 47 | 106 | 1449 |
314 | LIMB | 47 | 215 | 600 |
315 | MINOR | 47 | 279 | 1134 |
316 | NEONATAL | 47 | 158 | 786 |
317 | REGENERATION | 47 | 138 | 2835 |
318 | REVIEW | 47 | 122 | 714 |
319 | ALLOGENIC | 46 | 40 | 321 |
320 | CYCLOSPORINE | 46 | 361 | 2286 |
# | Word | Recs | TLCS | TGCS |
321 | GRAFT-VERSUS-LEUKEMIA | 46 | 1203 | 5659 |
322 | HIGHLY | 46 | 221 | 1000 |
323 | IMMUNITY | 46 | 297 | 1787 |
324 | NONHUMAN | 46 | 351 | 1427 |
325 | COMPLEX | 45 | 126 | 1214 |
326 | MYELOMA | 45 | 492 | 1692 |
327 | PERSISTENT | 45 | 227 | 724 |
328 | PROGENITORS | 45 | 300 | 3430 |
329 | PROSPECTIVE | 45 | 168 | 809 |
330 | SIBLING | 45 | 295 | 2689 |
331 | SMALL | 45 | 64 | 621 |
332 | VASCULAR | 45 | 335 | 2577 |
333 | BARRIERS | 44 | 552 | 1367 |
334 | EXPANSION | 44 | 82 | 852 |
335 | FOLLOW-UP | 44 | 161 | 882 |
336 | HEPATITIS | 44 | 98 | 1110 |
337 | HEPATOCYTES | 44 | 368 | 4237 |
338 | LEUKAEMIA | 44 | 138 | 526 |
339 | PROMOTES | 44 | 49 | 527 |
340 | T-CELL-DEPLETED | 44 | 792 | 2630 |
341 | ABSENCE | 43 | 170 | 744 |
342 | AML | 43 | 25 | 169 |
343 | DISORDERS | 43 | 158 | 629 |
344 | FLUORESCENT | 43 | 252 | 963 |
345 | HEMATOLOGICAL | 43 | 180 | 804 |
346 | IRRADIATED | 43 | 233 | 791 |
347 | MARKERS | 43 | 523 | 821 |
348 | MIGRATION | 43 | 219 | 1567 |
349 | CHEMOTHERAPY | 42 | 595 | 2837 |
350 | COMBINATION | 42 | 197 | 1260 |
# | Word | Recs | TLCS | TGCS |
351 | CONTROL | 42 | 166 | 1226 |
352 | DIABETES | 42 | 231 | 741 |
353 | DIABETIC | 42 | 198 | 1315 |
354 | FISH | 42 | 141 | 390 |
355 | HEMATOPOIESIS | 42 | 200 | 747 |
356 | IMPROVED | 42 | 274 | 3481 |
357 | INJECTION | 42 | 172 | 684 |
358 | POST | 42 | 38 | 328 |
359 | SWINE | 42 | 256 | 540 |
360 | AUTOIMMUNITY | 41 | 227 | 904 |
361 | CD3 | 41 | 115 | 447 |
362 | CLONAL | 41 | 613 | 3261 |
363 | CONTRIBUTE | 41 | 161 | 1628 |
364 | EPITHELIAL | 41 | 165 | 1511 |
365 | EPITHELIUM | 41 | 158 | 1816 |
366 | FATE | 41 | 159 | 1857 |
367 | FUTURE | 41 | 73 | 444 |
368 | HEPATIC | 41 | 164 | 2350 |
369 | LATE | 41 | 91 | 448 |
370 | MEDIATED | 41 | 58 | 422 |
371 | RED | 41 | 67 | 445 |
372 | STRATEGIES | 41 | 113 | 539 |
373 | SYNGENEIC | 41 | 616 | 1328 |
374 | BOWEL | 40 | 67 | 458 |
375 | BRAIN | 40 | 90 | 1447 |
376 | CURRENT | 40 | 87 | 688 |
377 | INCREASED | 40 | 283 | 1431 |
378 | INTRATHYMIC | 40 | 601 | 1453 |
379 | REPEAT | 40 | 404 | 579 |
380 | SELECTION | 40 | 132 | 738 |
# | Word | Recs | TLCS | TGCS |
381 | SEX-MISMATCHED | 40 | 224 | 549 |
382 | SIMULTANEOUS | 40 | 290 | 608 |
383 | STROMAL | 40 | 177 | 1322 |
384 | TOXICITY | 40 | 218 | 1376 |
385 | ALLOTRANSPLANTATION | 39 | 395 | 874 |
386 | CARCINOMA | 39 | 278 | 1624 |
387 | DELAYED | 39 | 171 | 609 |
388 | DOUBLE | 39 | 80 | 478 |
389 | EFFICACY | 39 | 158 | 824 |
390 | FIRST | 39 | 185 | 1134 |
391 | GLOBULIN | 39 | 154 | 667 |
392 | HEMOPOIETIC | 39 | 299 | 795 |
393 | POST-TRANSPLANT | 39 | 128 | 355 |
394 | REGULATION | 39 | 149 | 1083 |
395 | SCT | 39 | 101 | 244 |
396 | SIGNALING | 39 | 116 | 1096 |
397 | STRATEGY | 39 | 224 | 902 |
398 | TARGETING | 39 | 35 | 973 |
399 | CD25 | 38 | 131 | 807 |
400 | CONTRIBUTION | 38 | 174 | 1844 |